| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 08/30/2007 | WO2007096875A2 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor |
| 08/30/2007 | WO2007034329A3 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 08/30/2007 | US20070203180 e.g. 4-[(7-Hydroxy-2-ethyl-3-phenyl-4-quinolinyl)oxyphenyl]-2-propenoic acid; bone diseases, aging, osteoporosis, osteoarthritis, atherosclerosis, menopausal disorders,liver and cardiovascular disorder, breast cancer |
| 08/30/2007 | US20070203152 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203151 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203150 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 08/30/2007 | US20070203072 Hcv Ns-3 Serine Protease Inhibitors |
| 08/30/2007 | US20070202181 Low hygroscopic aripipazole drug substance and processes for the preparation thereof |
| 08/30/2007 | CA2643228A1 Novel polymorphs of montelukast ammonium salts and processes for preparation therefor |
| 08/29/2007 | EP1824838A1 Novel compounds |
| 08/29/2007 | EP1824830A1 Radiolabelled quinoline-based ligands for the 5-ht6 receptor functionality |
| 08/29/2007 | EP1824828A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/29/2007 | EP1824483A2 Muscarinic acetylcholine receptor antagonists |
| 08/29/2007 | EP1268431B1 3-cyanoquinolines,3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 08/29/2007 | CN101027295A Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 08/29/2007 | CN101024628A Aza-flavones, its preparing method and use |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/28/2007 | US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 08/28/2007 | US7262282 Fluorescence assay for kinase activity |
| 08/28/2007 | US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 08/28/2007 | CA2230960C Piperazine derivatives and process for the preparation thereof |
| 08/23/2007 | WO2007051828A3 Process for the preparation of a leukotriene antagonist and intermediates thereof |
| 08/23/2007 | US20070197587 Quinoline Derivatives as CRTH2 Antagonists |
| 08/23/2007 | US20070197586 8-Hydroxy-5-[(-Hydroxy-2-[[ (1R)-2-(4-Methoxyphenyl)-1-Methylethyl] Amino][Ethyl]-2(1H)-Quinolinone Monohydrochloride In Crystalline Form And The Process For Its Preparation |
| 08/23/2007 | US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone |
| 08/23/2007 | US20070197527 Bicyclic heteroaromatic compounds |
| 08/22/2007 | EP1819691A2 Biaryloxymethylarene carboxylic acids |
| 08/22/2007 | EP1819689A1 1-alkynyl-2-aryloxyalkylamides and their use as fungicides |
| 08/22/2007 | EP1819679A2 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
| 08/22/2007 | EP1819677A2 8-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1819676A2 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1819669A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 08/22/2007 | EP1819342A1 Quinoline tachykinin receptor antagonists |
| 08/22/2007 | EP1720870B1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments |
| 08/22/2007 | CN1332946C Premedicine acting on nervous centralis system |
| 08/22/2007 | CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists |
| 08/22/2007 | CN101023076A 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same |
| 08/22/2007 | CN101020658A Synthesis process of main cyclic quinoline compound |
| 08/21/2007 | US7259266 Benzopyran compounds useful for treating inflammatory conditions |
| 08/16/2007 | WO2007019397A3 6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus |
| 08/16/2007 | WO2006052555A8 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 08/16/2007 | US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation |
| 08/16/2007 | US20070191378 Anthranilic acid derivatives and their use as activators of the hm74a receptor |
| 08/16/2007 | US20070191358 Novel piperidine derivative for the treatment of depression |
| 08/16/2007 | US20070191345 3-((Hetero)arylsulfonyl)-8-'(aminoalkyl)oxyquinolines as 5-ht6 receptor antagonists for the treatment of cns disorders |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1817309A1 Acetamide compounds as fungicides |
| 08/15/2007 | EP1817305A2 Compounds for the treatment of cns and amyloid associated diseases |
| 08/15/2007 | EP1817289A1 New process for the preparation of a leukotriene antagonist |
| 08/15/2007 | EP1448531B1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/15/2007 | CN1331862C Di-aryl acid derivatives as PPAR receptor ligands |
| 08/15/2007 | CN101018770A PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 08/15/2007 | CN101018552A Intracellular receptor modulator compounds and methods |
| 08/15/2007 | CN101016263A Preparing method of 8-bromo-5,6-difluoro-2-methylquinoline |
| 08/14/2007 | US7256291 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; genetic probes for real-time detection; solid phase synthesis |
| 08/14/2007 | US7256204 6-(4-biphenylyl)methoxy-2-(2-(N,N-dimethylamino)ethyl)tetralin for example; inhibiting amyloid-beta protein production; for neurodegenerative diseases such as Alzheimer's disease |
| 08/14/2007 | CA2223414C Heteroaryl diol acids as leukotriene antagonists |
| 08/14/2007 | CA2206758C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 08/09/2007 | WO2007089030A1 Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| 08/09/2007 | WO2007088978A1 Novel quinoline derivative and pesticide for agricultural and horticultural applications comprising the derivative as active ingredient |
| 08/09/2007 | WO2007088545A2 Novel process for preparing 1-(mercaptomethyl) cyclopropaneacetic acid, a useful intermediate in the preparation of montelukast and salts thereof |
| 08/09/2007 | US20070185170 1,1'-(benzene-1,3-diylmethylene)bis[4-(4-chloro-N-methylanilino)pyridinium]dibromide, that inhibit phosphorylcholine biosynthesis by selective blocking of the choline kinase enzyme in tumor cells or in cells affected by parasitic infections; anticarcinogenic or antitumor agents; fungicides; viricides |
| 08/09/2007 | US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them |
| 08/09/2007 | US20070185079 Therapeutic agents I |
| 08/09/2007 | CA2636018A1 Inhibitors of fatty acid synthase (fas) |
| 08/08/2007 | EP1815860A2 Phosphate transport inhibitors |
| 08/08/2007 | EP1814872A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 08/08/2007 | EP1814869A2 Substituted amino acids as protein tyrosine phosphatase inhibitors |
| 08/08/2007 | EP1814857A1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 08/08/2007 | EP1814550A2 N-sulfonylpiperidine cannabinoid receptor 1 antagonists |
| 08/08/2007 | EP1708994B1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 08/08/2007 | EP1625116B1 Process for the preparation of carbostyril derivatives,such as aripiprazole and its intermediates |
| 08/08/2007 | CN1330984C Colored composition for color filter and color filter |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide |
| 08/08/2007 | CN1330627C Process for the synthesis of n-acyl-2-amino-4-alkoxy-5-nitrobenzoic acids |
| 08/08/2007 | CN101014581A Novel piperidine derivative for the treatment of depression |
| 08/08/2007 | CN101012195A Method of preparing 4-hydroxy-6-decyloxy-7-ethoxy-3-quinoline carboxylic acid ethyl ester |
| 08/07/2007 | US7253319 Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activity |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | US7253184 4-Phenoxyanilino-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes |
| 08/07/2007 | US7253173 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 08/02/2007 | US20070179315 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates |
| 08/02/2007 | US20070179263 Functional material comprising fluorine-containing compound |
| 08/02/2007 | US20070179180 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/02/2007 | US20070179165 Cyclic compounds |
| 08/02/2007 | US20070179132 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/01/2007 | EP1812416A1 Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to madulation of the dopamine d3 receptor |
| 08/01/2007 | EP1812398A1 Compounds having activity at nk3 receptor and uses thereof in medicine |
| 08/01/2007 | EP1812397A1 Process of making crystalline aripiprazole |
| 08/01/2007 | EP1812396A1 Crystalline aripiprazole solvates |
| 08/01/2007 | EP1812395A1 Method for the preparation of aripiprazole, and corresponding intermediates and their preparation |
| 08/01/2007 | EP1812394A2 Process for the preparation of montelukast and its salts |
| 08/01/2007 | EP1812393A2 "METHYL 2-[(3S)-[3-[(2E)-(7-CHLORO QUINOLIN-2-YL) ETHENYL] PHENYL]-3-HALOPROPYL] BENZOATES” |
| 08/01/2007 | CN1329399C Rare earth metal compounds and mixtures of these |
| 08/01/2007 | CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 08/01/2007 | CN101010298A Histone deacetylase inhibitor prodrugs |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7250517 Luminescent compounds |